Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis.

Frantz C, Pezet S, Avouac J, Allanore Y.

Dis Markers. 2018 Apr 1;2018:8509583. doi: 10.1155/2018/8509583. eCollection 2018.

2.

Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study.

Boleto G, Avouac J, Wipff J, Forien M, Dougados M, Roux C, Kahan A, Dieude P, Allanore Y.

Semin Arthritis Rheum. 2018 Feb 21. pii: S0049-0172(17)30737-0. doi: 10.1016/j.semarthrit.2018.02.010. [Epub ahead of print]

PMID:
29548542
3.

Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France.

Avouac J, Moltó A, Abitbol V, Etcheto A, Salcion A, Gutermann L, Klotz C, Elhai M, Cohen P, Soret PA, Morin F, Conort O, Chast F, Goulvestre C, Jeunne CL, Chaussade S, Kahan A, Roux C, Allanore Y, Dougados M.

Semin Arthritis Rheum. 2018 Apr;47(5):741-748. doi: 10.1016/j.semarthrit.2017.10.002. Epub 2017 Oct 5.

PMID:
29102156
4.

Prevalence and Disease-Specific Risk Factors for Lower Urinary Tract Symptoms in Systemic Sclerosis: An International Multicenter Study.

John G, Avouac J, Piantoni S, Polito P, Fredi M, Cozzi F, Airò P, Truchetet ME, Franceschini F, Allanore Y, Chizzolini C.

Arthritis Care Res (Hoboken). 2017 Oct 26. doi: 10.1002/acr.23454. [Epub ahead of print]

PMID:
29073343
5.

The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study.

John G, Allanore Y, Polito P, Piantoni S, Fredi M, Avouac J, Franceschini F, Truchetet ME, Cozzi F, Airo P, Chizzolini C.

Rheumatology (Oxford). 2017 Nov 1;56(11):1874-1883. doi: 10.1093/rheumatology/kex230.

PMID:
28977630
6.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
7.

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.

Avouac J, Guignabert C, Hoffmann-Vold AM, Ruiz B, Dorfmuller P, Pezet S, Amar O, Tu L, Van Wassenhove J, Sadoine J, Launay D, Elhai M, Cauvet A, Subramaniam A, Resnick R, Hachulla E, Molberg Ø, Kahan A, Humbert M, Allanore Y.

Arthritis Rheumatol. 2017 Nov;69(11):2209-2221. doi: 10.1002/art.40229. Epub 2017 Oct 17.

PMID:
28805015
8.

Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.

Avouac J, Konstantinova I, Guignabert C, Pezet S, Sadoine J, Guilbert T, Cauvet A, Tu L, Luccarini JM, Junien JL, Broqua P, Allanore Y.

Ann Rheum Dis. 2017 Nov;76(11):1931-1940. doi: 10.1136/annrheumdis-2016-210821. Epub 2017 Aug 11.

PMID:
28801346
9.

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Jaeger VK, Distler O, Maurer B, Czirják L, Lóránd V, Valentini G, Vettori S, Del Galdo F, Abignano G, Denton C, Nihtyanova S, Allanore Y, Avouac J, Riemekasten G, Siegert E, Huscher D, Matucci-Cerinic M, Guiducci S, Frerix M, Tarner IH, Garay Toth B, Fankhauser B, Umbricht J, Zakharova A, Mihai C, Cozzi F, Yavuz S, Hunzelmann N, Rednic S, Vacca A, Schmeiser T, Riccieri V, García de la Peña Lefebvre P, Gabrielli A, Krummel-Lorenz B, Martinovic D, Ancuta C, Smith V, Müller-Ladner U, Walker UA.

Rheumatology (Oxford). 2018 Mar 1;57(3):441-450. doi: 10.1093/rheumatology/kex182.

PMID:
28499034
10.

Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis.

Beyer C, Huscher D, Ramming A, Bergmann C, Avouac J, Guiducci S, Meier F, Vettori S, Siegert E, Jaeger VK, Maurer B, Riemekasten G, Walker U, Müller-Ladner U, Valentini G, Matucci-Cerinic M, Allanore Y, Distler O, Schett G, Distler JHW.

Ann Rheum Dis. 2018 Apr;77(4):626-628. doi: 10.1136/annrheumdis-2016-210834. Epub 2017 May 11. No abstract available.

PMID:
28495672
11.

Targeting synovial neoangiogenesis in rheumatoid arthritis.

Leblond A, Allanore Y, Avouac J.

Autoimmun Rev. 2017 Jun;16(6):594-601. doi: 10.1016/j.autrev.2017.04.005. Epub 2017 Apr 14. Review.

PMID:
28414154
12.

Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis.

Avouac J, Lepri G, Smith V, Toniolo E, Hurabielle C, Vallet A, Amrouche F, Kahan A, Cutolo M, Allanore Y.

Semin Arthritis Rheum. 2017 Aug;47(1):86-94. doi: 10.1016/j.semarthrit.2017.02.006. Epub 2017 Feb 10.

PMID:
28291582
13.
14.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors.

Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.

PMID:
27941129
15.

Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years.

Avouac J, Amrouche F, Meune C, Rey G, Kahan A, Allanore Y.

Semin Arthritis Rheum. 2017 Apr;46(5):537-543. doi: 10.1016/j.semarthrit.2016.10.007. Epub 2016 Oct 29.

PMID:
27908535
16.

Effects of rituximab in connective tissue disorders related interstitial lung disease.

Lepri G, Avouac J, Airò P, Anguita Santos F, Bellando-Randone S, Blagojevic J, Garcia Hernàndez F, Gonzalez Nieto JA, Guiducci S, Jordan S, Limaye V, Maurer B, Selva-O'Callaghan A, Riccieri V, Distler O, Matucci-Cerinic M, Allanore Y.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):181-185. Epub 2016 Oct 14.

17.

A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.

Koumakis E, Bouaziz M, Dieudé P, Cauvet A, Ruiz B, Airò P, Cusi D, Matucci-Cerinic M, Salvi E, Cuomo G, Hachulla E, Diot E, Caramaschi P, Riccieri V, Avouac J, Allanore Y.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):43-48. Epub 2016 Jul 1.

PMID:
27385538
18.

Time scale bias in erosion rates of glaciated landscapes.

Ganti V, von Hagke C, Scherler D, Lamb MP, Fischer WW, Avouac JP.

Sci Adv. 2016 Oct 5;2(10):e1600204. eCollection 2016 Oct.

19.

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.

Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y.

Ann Rheum Dis. 2017 Jan;76(1):270-276. doi: 10.1136/annrheumdis-2016-209768. Epub 2016 Sep 12.

PMID:
27621285
20.

N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosis.

Allanore Y, Komocsi A, Vettori S, Hachulla E, Hunzelmann N, Distler J, Avouac J, Gobeaux C, Launay D, Czirjak L, Kahan A, Meune C.

Int J Cardiol. 2016 Nov 15;223:385-389. doi: 10.1016/j.ijcard.2016.08.246. Epub 2016 Aug 13.

PMID:
27543715
21.

OX40L blockade protects against inflammation-driven fibrosis.

Elhai M, Avouac J, Hoffmann-Vold AM, Ruzehaji N, Amiar O, Ruiz B, Brahiti H, Ponsoye M, Fréchet M, Burgevin A, Pezet S, Sadoine J, Guilbert T, Nicco C, Akiba H, Heissmeyer V, Subramaniam A, Resnick R, Molberg Ø, Kahan A, Chiocchia G, Allanore Y.

Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):E3901-10. doi: 10.1073/pnas.1523512113. Epub 2016 Jun 13.

22.

Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey.

Frantz C, Avouac J, Distler O, Amrouche F, Godard D, Kennedy AT, Connolly K, Varga J, Matucci-Cerinic M, Allanore Y.

Semin Arthritis Rheum. 2016 Aug;46(1):115-23. doi: 10.1016/j.semarthrit.2016.02.005. Epub 2016 Feb 26.

PMID:
27132536
23.

Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.

Ruzehaji N, Frantz C, Ponsoye M, Avouac J, Pezet S, Guilbert T, Luccarini JM, Broqua P, Junien JL, Allanore Y.

Ann Rheum Dis. 2016 Dec;75(12):2175-2183. doi: 10.1136/annrheumdis-2015-208029. Epub 2016 Mar 9.

24.

Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.

Ponsoye M, Frantz C, Ruzehaji N, Nicco C, Elhai M, Ruiz B, Cauvet A, Pezet S, Brandely ML, Batteux F, Allanore Y, Avouac J.

Ann Rheum Dis. 2016 Dec;75(12):2142-2149. doi: 10.1136/annrheumdis-2015-208213. Epub 2016 Feb 24.

PMID:
26912566
25.

Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.

Huertas A, Phan C, Bordenave J, Tu L, Thuillet R, Le Hiress M, Avouac J, Tamura Y, Allanore Y, Jovan R, Sitbon O, Guignabert C, Humbert M.

Chest. 2016 Jun;149(6):1482-93. doi: 10.1016/j.chest.2016.01.004. Epub 2016 Jan 21.

PMID:
26836928
26.

Small, medium but not large arteries are involved in digital ulcers associated with systemic sclerosis.

Aïssou L, Meune C, Avouac J, Meunier M, Elhaï M, Sorbets E, Kahan A, Allanore Y.

Joint Bone Spine. 2016 Jul;83(4):444-7. doi: 10.1016/j.jbspin.2015.09.003. Epub 2015 Dec 29.

PMID:
26750764
27.

Skin Telangiectasia and the Identification of a Subset of Systemic Sclerosis Patients With Severe Vascular Disease.

Hurabielle C, Avouac J, Lepri G, de Risi T, Kahan A, Allanore Y.

Arthritis Care Res (Hoboken). 2016 Jul;68(7):1021-7. doi: 10.1002/acr.22766.

28.

Erosion by an Alpine glacier.

Herman F, Beyssac O, Brughelli M, Lane SN, Leprince S, Adatte T, Lin JY, Avouac JP, Cox SC.

Science. 2015 Oct 9;350(6257):193-5. doi: 10.1126/science.aab2386.

29.

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.

Romano E, Chora I, Manetti M, Mazzotta C, Rosa I, Bellando-Randone S, Blagojevic J, Soares R, Avouac J, Allanore Y, Ibba-Manneschi L, Matucci-Cerinic M, Guiducci S.

Ann Rheum Dis. 2016 Aug;75(8):1541-9. doi: 10.1136/annrheumdis-2015-207483. Epub 2015 Sep 10.

PMID:
26359450
30.

GEOMORPHOLOGY. Response to Comment on "Tectonic control of Yarlung Tsangpo Gorge revealed by a buried canyon in Southern Tibet".

Wang P, Scherler D, Liu-Zeng J, Mey J, Avouac JP, Zhang Y, Shi D.

Science. 2015 Aug 21;349(6250):799. doi: 10.1126/science.aaa9636.

31.

A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage.

Meune C, Khanna D, Aboulhosn J, Avouac J, Kahan A, Furst DE, Allanore Y.

Semin Arthritis Rheum. 2016 Feb;45(4):439-45. doi: 10.1016/j.semarthrit.2015.07.002. Epub 2015 Jul 4.

PMID:
26272194
32.

Slip pulse and resonance of the Kathmandu basin during the 2015 Gorkha earthquake, Nepal.

Galetzka J, Melgar D, Genrich JF, Geng J, Owen S, Lindsey EO, Xu X, Bock Y, Avouac JP, Adhikari LB, Upreti BN, Pratt-Sitaula B, Bhattarai TN, Sitaula BP, Moore A, Hudnut KW, Szeliga W, Normandeau J, Fend M, Flouzat M, Bollinger L, Shrestha P, Koirala B, Gautam U, Bhatterai M, Gupta R, Kandel T, Timsina C, Sapkota SN, Rajaure S, Maharjan N.

Science. 2015 Sep 4;349(6252):1091-5. doi: 10.1126/science.aac6383. Epub 2015 Aug 6.

33.

All-cause Mortality Associated with TNF-α Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials.

Poiroux L, Allanore Y, Kahan A, Avouac J.

Am J Med. 2015 Dec;128(12):1367-73.e1. doi: 10.1016/j.amjmed.2015.07.020. Epub 2015 Aug 3.

PMID:
26247564
34.

Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.

Avouac J, Riemekasten G, Meune C, Ruiz B, Kahan A, Allanore Y.

J Rheumatol. 2015 Oct;42(10):1801-7. doi: 10.3899/jrheum.150061. Epub 2015 Aug 1.

PMID:
26233500
35.

Late Nailfold Videocapillaroscopy Pattern Associated With Hand Calcinosis and Acro-Osteolysis in Systemic Sclerosis.

Morardet L, Avouac J, Sammour M, Baron M, Kahan A, Feydy A, Allanore Y.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):366-73. doi: 10.1002/acr.22672.

36.

Outcome of Patients with Systemic Sclerosis in the Intensive Care Unit.

Pène F, Hissem T, Bérezné A, Allanore Y, Geri G, Charpentier J, Avouac J, Guillevin L, Cariou A, Chiche JD, Mira JP, Mouthon L.

J Rheumatol. 2015 Aug;42(8):1406-12. doi: 10.3899/jrheum.141617. Epub 2015 Jul 1.

PMID:
26136487
37.

INDUCED SEISMICITY. Seismicity triggered by fluid injection-induced aseismic slip.

Guglielmi Y, Cappa F, Avouac JP, Henry P, Elsworth D.

Science. 2015 Jun 12;348(6240):1224-6. doi: 10.1126/science.aab0476. Epub 2015 Jun 11.

38.

Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.

Ruzehaji N, Avouac J, Elhai M, Frechet M, Frantz C, Ruiz B, Distler JH, Allanore Y.

Arthritis Res Ther. 2015 May 30;17:145. doi: 10.1186/s13075-015-0659-5.

39.

Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.

Hachulla E, Hatron PY, Carpentier P, Agard C, Chatelus E, Jego P, Mouthon L, Queyrel V, Fauchais AL, Michon-Pasturel U, Jaussaud R, Mathian A, Granel B, Diot E, Farge-Bancel D, Mekinian A, Avouac J, Desmurs-Clavel H, Clerson P; SEDUCE study group.

Ann Rheum Dis. 2016 Jun;75(6):1009-15. doi: 10.1136/annrheumdis-2014-207001. Epub 2015 May 20.

40.

Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.

Arismendi M, Giraud M, Ruzehaji N, Dieudé P, Koumakis E, Ruiz B, Airo P, Cusi D, Matucci-Cerinic M, Salvi E, Cuomo G, Hachulla E, Diot E, Caramaschi P, Riccieri V, Avouac J, Kayser C, Allanore Y.

Arthritis Res Ther. 2015 Mar 21;17:71. doi: 10.1186/s13075-015-0572-y.

41.

Digital ulcers predict a worse disease course in patients with systemic sclerosis.

Mihai C, Landewé R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, Ionescu R, Rednic S, Allanore Y, Avouac J, Czirják L, Hachulla E, Riemekasten G, Cozzi F, Airò P, Cutolo M, Mueller-Ladner U, Matucci-Cerinic M; EUSTAR co-authors.

Ann Rheum Dis. 2016 Apr;75(4):681-6. doi: 10.1136/annrheumdis-2014-205897. Epub 2015 Feb 16.

PMID:
25688073
42.

Targeting CD226/DNAX accessory molecule-1 (DNAM-1) in collagen-induced arthritis mouse models.

Elhai M, Chiocchia G, Marchiol C, Lager F, Renault G, Colonna M, Bernhardt G, Allanore Y, Avouac J.

J Inflamm (Lond). 2015 Feb 8;12:9. doi: 10.1186/s12950-015-0056-5. eCollection 2015.

43.

Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.

Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y.

Arthritis Care Res (Hoboken). 2015 Jul;67(7):1022-30. doi: 10.1002/acr.22547.

44.

Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.

Tomcik M, Palumbo-Zerr K, Zerr P, Sumova B, Avouac J, Dees C, Distler A, Becvar R, Distler O, Schett G, Senolt L, Distler JH.

Ann Rheum Dis. 2016 Mar;75(3):609-16. doi: 10.1136/annrheumdis-2014-206234. Epub 2015 Jan 20.

PMID:
25603829
45.

Systemic sclerosis: Recent insights.

Elhai M, Avouac J, Kahan A, Allanore Y.

Joint Bone Spine. 2015 May;82(3):148-53. doi: 10.1016/j.jbspin.2014.10.010. Epub 2014 Dec 31. Review.

PMID:
25557659
46.

Trabecular bone score in female patients with systemic sclerosis: comparison with rheumatoid arthritis and influence of glucocorticoid exposure.

Koumakis E, Avouac J, Winzenrieth R, Toth E, Payet J, Kahan A, Allanore Y, Cormier C.

J Rheumatol. 2015 Feb;42(2):228-35. doi: 10.3899/jrheum.140752. Epub 2014 Dec 1.

PMID:
25448793
47.

Tectonic control of Yarlung Tsangpo Gorge revealed by a buried canyon in Southern Tibet.

Wang P, Scherler D, Liu-Zeng J, Mey J, Avouac JP, Zhang Y, Shi D.

Science. 2014 Nov 21;346(6212):978-81. doi: 10.1126/science.1259041.

48.

Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms.

Tauber M, Avouac J, Benahmed A, Barbot L, Coustet B, Kahan A, Allanore Y.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-82-7. Epub 2014 Nov 3.

PMID:
25372792
49.

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, Hachulla E, Valentini G, Carreira PE, Cozzi F, Balbir Gurman A, Braun-Moscovici Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, Müller-Ladner U, Kahan A, Distler O, Allanore Y; EUSTAR co-authors.

Ann Rheum Dis. 2016 Jan;75(1):163-9. doi: 10.1136/annrheumdis-2014-206386. Epub 2014 Oct 23.

PMID:
25342760
50.

Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.

Payet J, Goulvestre C, Bialé L, Avouac J, Wipff J, Job-Deslandre C, Batteux F, Dougados M, Kahan A, Allanore Y.

J Rheumatol. 2014 Dec;41(12):2395-402. doi: 10.3899/jrheum.131375. Epub 2014 Oct 1. Erratum in: J Rheumatol. 2015 Mar;42(3):558.

PMID:
25274898

Supplemental Content

Loading ...
Support Center